The company plans five new product approvals in 2025, including Blenrep for multiple myeloma and depemokimab for severe ...
Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact The Gross Law Firm
NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE ... status updates throughout the lifecycle of the case.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback